About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company” or "Solid”), a life sciences company developing precision genetic ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...
SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant in the Phase 1b FALCON trial has been completed, with initial data expected ...
Discover Magazine on MSN
Aging brains show surprising mix of decline and adaptation
Learn more about the new study, which highlights the importance of analyzing brain structure and connectivity simultaneously.
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
Nanoflowers, which look white, can help healthy cells, colored yellow, deliver mitochondria, colored red, to nearby cells. Akhilesh K. Gaharwar Most of your cells rely on microscopic structures within ...
The glial-specific role of betaPix during cerebral blood vessel development has been revealed by establishing a new betaPix conditional trap allele in zebrafish.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback